Türkiye Change Country

KCI Launches Novel Tool to Simplify Epidermal Harvesting

Released : 9 Temmuz 2013

CelluTome™ Epidermal Harvesting System makes harvesting and subsequent grafting of epidermis accessible to more clinicians and patients

SAN ANTONIO, July 9, 2013 Kinetic Concepts, Inc. today announced that its CelluTome™ Epidermal Harvesting System is commercially available in the US. The CelluTome™ Epidermal Harvesting System offers an automated, precise and reproducible process of harvesting autologous, non-damaged epidermal tissue. The simplicity of the new system makes the benefits of epidermal grafting accessible to a much broader range of clinicians and patients than before.

“The CelluTome™ System allows for a simplified and convenient way to harvest epidermis and provide autologous epidermal micrografts,” said Robert Kirsner, MD, PhD, professor and vice chairman, Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine. “Our experience, to date confirms harvesting with minimal, if any, pain and scarring and, most importantly, the ability to graft epidermis to help heal patients’ wounds.”

This new skin harvesting platform will enable physicians to harvest epidermal grafts consistently and reliably while minimizing donor site complications. The product is designed to harvest epidermis at the DE junction1, which allows skin harvesting without the need for donor site anesthesia. The epidermal micrografts harvested with the CelluTome™ System can be used in conjunction with KCI V.A.C.® Therapy.

“The CelluTome™ Epidermal Harvesting System addresses an unmet need in acquiring skin grafts and gives a broad range of physicians the ability to manage wounds effectively,” said Joe Woody, president and CEO, KCI. “The beauty of this new tool is that it provides a skin graft without damaging the donor site. This means the whole process can take place in an outpatient setting, which truly transforms the way physicians have traditionally used skin grafting.”

For more information about KCI, visit www.kci1.com. For more information about the CelluTome™ System, please visit www.cellutome.com.


About KCI
Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 25 countries around the world. Headquartered in San Antonio, Texas, KCI is committed to advancing the science of healing and positively impacting patient care by developing customer-driven innovations to meet the evolving needs of healthcare professionals. Proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on more than 7 million wounds worldwide. Additional information about KCI and its products is available at  www.KCI1.com.


Mike Barger
KCI Corporate Communications
Phone: 210-255-6824
Email: mike.barger@kci1.com


1. Powers KA, Kim PJ, Attinger CE, et al. Early Experience with Negative Pressure Wound Therapy with Instillation in Acutely Infected Wounds. Poster presented at the 2013 Symposium of Advanced Wound Care (SAWC) Spring Conference, May 1-5, 2013, Denver, CO.
2. Timmers MS, Graafland N, Bernards AT, Nelissen RG, van Dissel JT, Jukema GN. Negative pressure wound treatment with polyvinyl alcohol foam and polyhexanide antiseptic solution instillation in posttraumatic osteomyelitis. Wound Repair Regen 2009 March 1;17(2):278-86.
3. Gabriel A, Shores J., Heinrich C, et al. Negative pressure wound therapy with instillation: a pilot study describing a new method for treating infected wounds. Int Wound J 2008 June 1; 5(3):399-413.

Hastalara Yönelik Önemli Mesaj

Yasal Uyarı | Gizlilik Politikası | Bize Ulaşın

Telif Hakkı © 1998 – 2013 KCI Licensing, Inc Tüm Hakları Saklıdır.     DSL#12-0298.TR
Bu Web sitesinde yer alan bilgiler yalnızca Türkiye'de görüntülenecek şekilde ve bu amaçla hazırlanmışlardır. Bu Web sitesi, farklı ülkelerde bulunan veya bulunmayan ve mümkünse, farklı ülkelerde farklı göstergeler ve sınırlamalar için bir düzenleyici makam tarafından onay veya izin almış ya da almamış olan ürünler hakkında bilgiler içerir.